← 返回前沿论文

GPCR-Gα13 信号通过迁移至富含细胞因子的微环境调控肠道上皮内 CD8(+) 淋巴细胞的存活

英文原题:GPCR-Gα13 signaling regulates survival of intestinal intraepithelial CD8(+) lymphocytes through migration to cytokine-rich niches.

PubMed 2026/08/17(内容时间) Immunity Q1 · IF 30.6(JCR 2025)

研究概要

肠道上皮内淋巴细胞(IELs),包括常规 CD8αβ T 组织驻留记忆(Trm)细胞和非常规 CD8αα T 细胞,促进组织完整性。

中文摘要

肠道上皮内淋巴细胞(IELs),包括常规 CD8αβ T 组织驻留记忆(Trm)细胞和非常规 CD8αα T 细胞,促进组织完整性。在此,我们研究了调控 IEL 定位、稳态和功能的 G 蛋白偶联受体信号。异三聚体 G 蛋白亚基 Gα13 或其效应分子 Arhgef1 的缺陷导致所有类型的 CD8 + TCRαβ 和 TCRγδ IELs 出现肠道特异性丢失。Gα13 缺陷的 IELs 表现出受限的上皮内运动和成熟受损。在缺乏 Gα13 信号的情况下,感染诱导的肠道 CD8αβ + Trm 细胞生成完好,但这些细胞难以进入绒毛微环境,且存活存在缺陷,而增加 TGF-β 或白细胞介素(IL)-15 可挽救这一缺陷。体内 CRISPR-Cas9 筛选鉴定出 GPR132 是一种 Gα13 偶联受体,可调控 CD8αβ + IEL 稳态以及向溶血磷脂酰胆碱的迁移。携带 Gα13 缺陷 T 细胞的小鼠遭受更严重的结肠炎,且结直肠肿瘤生长增加。Gα13 信号对 IEL 在绒毛微环境中定位和存活的选择性需求对治疗干预具有重要意义。

展开英文摘要原文

Intestinal intraepithelial lymphocytes (IELs), including conventional CD8αβ T resident memory (Trm) cells and unconventional CD8αα T cells, promote tissue integrity. Here, we studied the G-protein coupled receptor signals regulating IEL positioning, homeostasis, and function. Deficiency in heterotrimeric G-protein subunit Gα13 or its effector Arhgef1 caused an intestine-specific loss of all types of CD8 + TCRαβ and TCRγδ IELs. Gα13-deficient IELs exhibited restricted intraepithelial movement and impaired maturation. Induction of intestinal CD8αβ + Trm cells upon infection was intact in the absence of Gα13-signaling, but the cells had poor access to the villous niche and defective survival that could be rescued by increasing TGF-β or interleukin (IL)-15. In vivo CRISPR-Cas9 screening identified GPR132 as a Gα13-coupled receptor that regulates CD8αβ + IEL homeostasis and migration to lysophosphatidylcholine. Mice bearing Gα13-deficient T cells suffered more severe colitis and increased colorectal tumor growth. The selective requirement for Gα13 signaling for IEL positioning and survival in the villous niche has implications for therapeutic intervention.

论文信息

作者
Earley ZM、Rao A、Qiu L、Knöpper K、Peng F、Jo N、Krishnapura A、Lisicka W
第一作者单位
Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA. Electronic address: zach.earley@ucsf.edu.United States
通讯作者单位
Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA. Electronic address: jason.cyster@ucsf.edu.United States
期刊
Immunity2026 Sep 8
原文标识
PubMed 42607677 · DOI 10.1016/j.immuni.2026.07.021